CLINICAL_TRIALS
trial_result
· 2012-10-30
Clinical Trial Update: Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma [Phase 2]
Summary
A Phase 2 trial evaluated lenalidomide (Revlimid) for advanced ocular (uveal) melanoma; the study completed and results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2012-10-30